Cargando…
Gaining the hard yard: pre-clinical evaluation of lentiviral-mediated gene therapy for the treatment of β-thalassemia
Gene therapy is one potential novel therapeutic avenue for the treatment of inherited monogenic disorders. Diseases of the blood are frequent targets for gene therapy because it is relatively easy to harvest haematopoietic stem cells (HSCs) from the bone marrow, genetically modify the cells ex vivo,...
Autores principales: | Milsom, Michael D, Williams, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377332/ https://www.ncbi.nlm.nih.gov/pubmed/20677209 http://dx.doi.org/10.1002/emmm.201000086 |
Ejemplares similares
-
Assessing metastasis risk after pre-operative anti-angiogenic therapy
por: Biziato, Daniela, et al.
Publicado: (2014) -
Telomerase gene therapy: a novel approach to combat aging
por: Boccardi, Virginia, et al.
Publicado: (2012) -
Single stem cell gene therapy for genetic skin disease
por: Larsimont, Jean-Christophe, et al.
Publicado: (2015) -
A surrogate marker for Aβ42 production in the CNS
por: Holtzman, David M
Publicado: (2009) -
Hepcidin and iron-mediated resistance to malaria
por: Prentice, Andrew M
Publicado: (2011)